Maxygen (MAXY)

Add to Watchlists Create an Alert
2.38 +0.00  +0.00%   NASDAQ May 24, 2:08PM BATS Real time Currency in USD

Maxygen News

Maxygen (MAXY) Narrows Q1 Loss
Street Insider May 3

Maxygen Reports First Quarter 2013 Financial Results
Business Wire May 3

Maxygen, Inc. , a biopharmaceutical company, today announced financial and business results for the quarter ended March 31, 2013.

Maxygen Reports Fourth Quarter and Year End 2012 Financial Results
Business Wire Mar 12

Maxygen, Inc. , a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2012.

Maxygen Announces Tax Treatment of 2012 Cash Distribution
noodls Jan 30

January 29, 2013 SAN MATEO, Calif., January 29, 2013 ─ Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced that its distribution of cash in September 2012 primarily will be classified ...

Maxygen Announces Tax Treatment of 2012 Cash Distribution
Business Wire Jan 29

Maxygen, Inc. , a biotechnology company, today announced that its distribution of cash in September 2012 primarily will be classified as a return of capital to its stockholders for U.S.

Maxygen Announces Third Quarter 2012 Financial Results
noodls Nov 6

November 6, 2012 SAN MATEO, Calif., November 6, 2012 ─ Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced financial and business results for the quarter ended September 30, 2012. Third ...

Maxygen Inc. Stock Downgraded (MAXY)
Sep 11

Maxygen (Nasdaq:MAXY) has been downgraded by TheStreet Ratings from from a buy to hold.

Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
MAXY 2.38 +0.00 +0.00% 66.15M
New watchlist
Create
Success.

Your new watchlist has been created

View WatchlistsDone
Create Watchlist from Quotes

Register for your Free YCharts Account.

Understand your investments with more data than any other free site.

  • Create watchlists that you care about for stocks or economic indicators
  • Create alerts to track the movements of your stocks
  • Access stock analysis from our in-house experts
Get Started Now

Already registered? Sign in to your account.

document.write('');